B
Braidwell Portfolio holdings
AUM
$2.92B
This Quarter Return
-5.74%
1 Year Return
-4.59%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$3.16B
AUM Growth
+$3.16B
(+3.4%)
Cap. Flow
+$195M
Cap. Flow
% of AUM
6.15%
Top 10 Holdings %
Top 10 Hldgs %
35.35%
Holding
100
New
14
Increased
28
Reduced
11
Closed
11
Top Buys
| 1 |
BCYC
Bicycle Therapeutics
BCYC
|
$25.9M |
| 2 |
89bio
ETNB
|
$24.6M |
| 3 |
Thermo Fisher Scientific
TMO
|
$24.5M |
| 4 |
Boston Scientific
BSX
|
$23.6M |
| 5 |
Immunocore
IMCR
|
$22.8M |
Top Sells
| 1 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
$47.8M |
| 2 |
Biogen
BIIB
|
$34.7M |
| 3 |
Align Technology
ALGN
|
$30.2M |
| 4 |
Aclaris Therapeutics
ACRS
|
$30.1M |
| 5 |
Glaukos
GKOS
|
$26.2M |
Sector Composition
| 1 | Healthcare | 51.8% |
| 2 | Consumer Staples | 0.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Neurocrine Biosciences
NBIX
$13.8B
| $109M | 3.44% | 968,024 +34,662 | +4% | +$3.9M |
|
2
Vaxcyte
PCVX
$4B
| $82.6M | 2.61% | 1,619,553 -102,800 | -6% | -$5.24M |
|
3
Xenon Pharmaceuticals
XENE
$2.98B
| $71.9M | 2.27% | 2,103,396 +275,043 | +15% | +$9.4M |
|
|
4
Boston Scientific
BSX
$156B
| $61.5M | 1.94% | 1,164,850 +447,800 | +62% | +$23.6M |
|
5
Legend Biotech
LEGN
$6.41B
| $59.1M | 1.87% | 879,564 +323,263 | +58% | +$21.7M |
|
6
iRhythm Technologies
IRTC
$5.46B
| $53.6M | 1.69% | 568,157 +89,600 | +19% | +$8.45M |
|
|
7
Glaukos
GKOS
$5.5B
| $52.4M | 1.65% | 695,792 -348,600 | -33% | -$26.2M |
|
|
8
Immunocore
IMCR
$1.62B
| $47.1M | 1.49% | 906,973 +438,946 | +94% | +$22.8M |
|
9
Day One Biopharmaceuticals
DAWN
$769M
| $45.6M | 1.44% | 3,715,573 +353,760 | +11% | +$4.34M |
|
10
Natera
NTRA
$23.1B
| $44.8M | 1.42% | 1,012,145 -140,706 | -12% | -$6.23M |
|
11
Keros Therapeutics
KROS
$618M
| $43.3M | 1.37% | 1,357,309 +213,444 | +19% | +$6.8M |
|
|
DCPH
12
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $42.4M | 1.34% | 3,336,221 -310,198 | -9% | -$3.95M |
|
|
FNA
13
DELISTED
Paragon 28, Inc.
FNA
| $42.2M | 1.33% | 3,361,824 +1,225,702 | +57% | +$15.4M |
|
14
Maravai LifeSciences
MRVI
$350M
| $39.7M | 1.26% | 3,974,857 +2,170,157 | +120% | +$21.7M |
|
|
15
Thermo Fisher Scientific
TMO
$186B
| $38.3M | 1.21% | 75,749 +48,449 | +177% | +$24.5M |
|
|
16
Align Technology
ALGN
$10.3B
| $38.2M | 1.21% | 125,213 -98,817 | -44% | -$30.2M |
|
17
BioCryst Pharmaceuticals
BCRX
$1.74B
| $38M | 1.2% | 5,362,980 +2,571,100 | +92% | +$18.2M |
|
|
NVRO
18
DELISTED
NEVRO CORP.
NVRO
| $34.1M | 1.08% | 1,776,368 | – | – |
|
19
OrthoPediatrics
KIDS
$536M
| $33.8M | 1.07% | 1,057,770 +296,562 | +39% | +$9.49M |
|
20
Intuitive Surgical
ISRG
$170B
| $33.6M | 1.06% | 114,920 -8,900 | -7% | -$2.6M |
|
21
Viridian Therapeutics
VRDN
$1.5B
| $26.6M | 0.84% | 1,735,182 +528,882 | +44% | +$8.11M |
|
22
Alector
ALEC
$238M
| $26.4M | 0.83% | 4,074,120 -57,195 | -1% | -$371K |
|
23
Outset Medical
OM
$247M
| $26.1M | 0.83% | 2,400,427 +940,059 | +64% | +$10.2M |
|
24
Harrow
HROW
$1.44B
| $26M | 0.82% | 1,808,684 +356,146 | +25% | +$5.12M |
|
|
BCYC
25
Bicycle Therapeutics
BCYC
$511M
| $25.9M | 0.82% | +1,289,872 | New | +$25.9M |
|